Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00120211
Status:
COMPLETED
Last Update Posted:
2011-10-13
First Post:
2005-07-08
Brief Title:
Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
Sponsor:
International Atomic Energy Agency
Organization:
International Atomic Energy Agency
Study Overview
Official Title:
Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
Status:
COMPLETED
Status Verified Date:
2011-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial compares the use of 6 fractions versus the standard 5 fractions of radiotherapy used in the treatment of head and neck cancer
Detailed Description:
The purpose of this trial is to study the clinical effects of increasing the weekly fraction number for locally advanced head and neck cancers by a multi-institutional prospective randomised trial The primary endpoint is to clarify whether a six fraction per week protocol has a greater effect on the survival as compared to the conventional five fraction per week protocol
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None